Glucose Health, Inc.
Datakwaliteit: 100%
GLUC
OTC
Manufacturing
Chemicals
€ 0,39
▼
€ 0,01
(-2,50%)
Marktkapitalisatie: 7,71 M
Prijs
€ 0,44
Marktkapitalisatie
7,71 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—
Quick Summary
Belangrijkste Punten
Negative free cash flow of -17.253,0
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)7232,14%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
N/A
ROICN/A
Net Margin-96,52%
Op. Margin-36,82%
Veiligheid
Debt / Equity
N/A
Current Ratio0,06
Interest Coverage-0,29
Waardering
PE (TTM)
-90,68
Onder sectorgemiddelde (-1,47)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -90,7 | -1,5 |
| P/B | — | 1,6 |
| ROE % | — | -53,3 |
| Net Margin % | -96,5 | -41,5 |
| Rev Growth 5Y % | — | 1,8 |
| D/E | — | 0,3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 7232,14% | Revenue Growth (3Y) | 969,39% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 88.130,0 | Net Income (TTM) | -85.062,0 |
| ROE | N/A | ROA | -316,98% |
| Gross Margin | 65,39% | Operating Margin | -36,82% |
| Net Margin | -96,52% | Free Cash Flow (TTM) | -17.253,0 |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0,06 |
| Interest Coverage | -0,29 | Asset Turnover | 3,28 |
| Working Capital | -426.427 | Tangible Book Value | -426.232 |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -90,68 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | 87,52 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -0,22% | ||
| Market Cap | 7,71 M | Enterprise Value | 7,70 M |
| Per Share | |||
| EPS (Diluted TTM) | N/A | Revenue / Share | 0,01 |
| FCF / Share | 0,00 | OCF / Share | 0,00 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 20,28% |
| SBC-Adj. FCF | -18.159 | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|
| Revenue | 313.229,0 | 4.272,0 | 2.739,0 | -224,0 | — |
| Net Income | -410.443,0 | -266.064,0 | -669.409,0 | -2,03 M | -568.650,0 |
| EPS (Diluted) | — | — | — | — | — |
| Gross Profit | 19.167,0 | 397,0 | -20.725,0 | -5.723,0 | -3.632,0 |
| Operating Income | -86.647,0 | -156.173,0 | -545.216,0 | -1,80 M | -532.479,0 |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 48,0 | 48,0 | 4.000,0 | — | — |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | — | — | — | — |
| Interest Expense | 323.796,0 | 120.028,0 | 109.631,0 | 205.033,0 | 36.171,0 |
| Income Tax | — | — | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|
| Total Assets | 33.145,0 | 15.407,0 | 44.030,0 | 25.590,0 | 207.676,0 |
| Total Liabilities | 528.592,0 | 403.226,0 | 324.582,0 | 223.348,0 | 185.476,0 |
| Shareholders' Equity | -495.447,0 | -387.819,0 | -280.552,0 | -197.758,0 | 22.200,0 |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 20.542,0 | 2.055,0 | 711,0 | 1.076,0 | 82,0 |
| Current Assets | 32.905,0 | 15.107,0 | 43.730,0 | 25.590,0 | 1.076,0 |
| Current Liabilities | 528.592,0 | 403.226,0 | 324.582,0 | 223.348,0 | 185.476,0 |
{"event":"ticker_viewed","properties":{"ticker":"GLUC","listing_kind":"stock","pathname":"/stocks/gluc","exchange":"OTC","country":"US"}}